Stock listing

Neurobiological Technologies Inc (NTII) Stock Price, News, Filings & Events

Selected listing: NTII · OTC · USD · US

This page tracks Neurobiological Technologies Inc's NTII:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NTII:OTC. NTII:OTC is the selected stock listing for investors researching Neurobiological Technologies Inc; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to NTII:OTC. Neurobiological Technologies Inc (NTII) is a public company based in the United States, focusing on innovative solutions in the field of neurobiology. With a market capitalization of $27. 02 million, NTII is engaged in developing therapies aimed at addressing various neurological conditions. The company is committed to advancing its research and product offerings to improve patient outcomes.

websiteNTII:OTCUSDUSSEO content: aiUpdated June 26, 2026/stock/otc-ntii/neurobiological-technologies-inc/l-rmbfxqmlil
Neurobiological Technologies Inc logo
Ticker
NTII:OTC
Asset type
Stock
Market cap
$27
Sector
Health Technology
Industry
Biotechnology
Exchange
OTC
Currency
USD

Neurobiological Technologies Inc NTII:OTC stock context

This page tracks Neurobiological Technologies Inc's NTII:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NTII:OTC. NTII:OTC is the selected stock listing for investors researching Neurobiological Technologies Inc; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to NTII:OTC. Neurobiological Technologies Inc (NTII) is a public company based in the United States, focusing on innovative solutions in the field of neurobiology. With a market capitalization of $27. 02 million, NTII is engaged in developing therapies aimed at addressing various neurological conditions. The company is committed to advancing its research and product offerings to improve patient outcomes.

Research Neurobiological Technologies Inc